Pharmaron Beijing Market Cap

Pharmaron Beijing has a market cap or net worth of 48.92 billion as of December 5, 2025. Its market cap has decreased by -4.21% in one year.

Market Cap

48.92B

Enterprise Value

53.60B

Revenue

13.54B

Ranking

n/a

PE Ratio

34.12

Stock Price

29.21

Market Cap Chart

Since January 28, 2019, Pharmaron Beijing's market cap has increased from 7.24B to 48.92B, an increase of 575.82%. That is a compound annual growth rate of 32.13%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	48.92B	16.91%
Dec 31, 2024	41.85B	-11.66%
Dec 29, 2023	47.37B	-38.44%
Dec 30, 2022	76.95B	-27.67%
Dec 31, 2021	106.40B	12.84%
Dec 31, 2020	94.29B	140.25%
Dec 31, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Jiangsu Hengrui Pharmaceuticals Co.,Ltd	409.56B
WuXi AppTec	269.55B
Shenzhen Mindray Bio-Medical Electronics	244.77B
Sichuan Biokin Pharmaceutical	150.71B
Shanghai United Imaging Healthcare	105.68B
Aier Eye Hospital Group	105.04B
Zhangzhou Pientzehuang Pharmaceutical.,	101.93B
Yunnan Baiyao Group Co.,Ltd	99.79B

Market Cap Rankings